1Y Annualised Return
▼-40.46%
3Y Annualised Return
▼-18.68%
5Y Annualised Return
▼-11.78%
10Y Annualised Return
▼-0.60%
|
|
|
Over the past
Market Cap (in crs)
118.81
Face Value
10
Turnover (in lacs)
8.45
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
57.35 Cr | 73.04 Cr | 88.71 Cr | 79.94 Cr | 76.54 Cr |
Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
---|---|---|---|
318.73 Cr | 368.69 Cr | 533.48 Cr | 303.32 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
-13.8 Cr | 0.06 Cr | 1.29 Cr | 2.69 Cr | 2.68 Cr |
Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
---|---|---|---|
6.72 Cr | -9.07 Cr | 12.31 Cr | 2.65 Cr |
Mangalam Drugs and Organics Ltd reported a 43.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 25.1%.
Its expenses for the quarter were down by 28.5% QoQ and 7.4% YoY.
The net profit decreased 490.9% QoQ and decreased 614.9% YoY.
The earnings per share (EPS) of Mangalam Drugs and Organics Ltd declined at 8.7 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 10433 Rs | 13052 Rs |
Week Rs | 15016 Rs | 21708 Rs |
Month Rs | 15782 Rs | 29217 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.91 | 105.76 | 1.84 | 4.32 | 1.91 | 0.00% | -1.55% | -9.05% | -45.43% | -28.46% | 0.00% | 31.83 | 62.55 | 1.59 | |
850.00 | 102.00 | 736 | 1190 | 857.50 | -0.95% | 2.16% | 2.32% | -19.16% | 46.00% | 0.41% | 27.04 | 41.05 | 1.90 | |
0.98 | 99.50 | 0.83 | 4.36 | 0.98 | 4.26% | 0.00% | -8.41% | -72.24% | -88.70% | 0.00% | 0.00 | 41.05 | 0.91 | |
5.26 | 123.90 | 2.82 | 6.25 | 5.28 | -1.87% | 4.16% | 61.85% | 44.51% | 549.38% | 0.00% | 263.00 | 41.05 | 3.96 | |
Zenith Drugs Ltd. | - | 68.00 | - | - | - | - | - | - | - | - | - | - | - | - |
61.90 | 123.82 | 53.85 | 104.9 | 57.89 | 6.74% | -0.96% | -19.06% | 0.00% | 0.00% | 0.00% | 11.55 | 41.05 | 1.79 |
Mangalam Drugs and Organics share price is ₹75.06 in NSE and ₹74.96 in BSE as on 16/9/2025.
Mangalam Drugs and Organics share price in the past 1-year return was -44.84. The Mangalam Drugs and Organics share hit a 1-year low of Rs. 70.1 and a 1-year high of Rs. 140.5.
The market cap of Mangalam Drugs and Organics is Rs. 118.81 Cr. as of 16/9/2025.
The PE ratios of Mangalam Drugs and Organics is 0 as of 16/9/2025.
The PB ratios of Mangalam Drugs and Organics is 0.79 as of 16/9/2025
You can easily buy Mangalam Drugs and Organics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Mangalam Drugs and Organics share price is ₹140.5 and ₹70.1 as of 16/9/2025.
The earnings per share (EPS) of Mangalam Drugs and Organics declined at 8.7 during Q1 FY 2025-26.
Please be aware that Mangalam Drugs and Organics stock prices are subject to continuous fluctuations due to various factors.